CD20-directed Antibody Interactions

CD20-directed Cytolytic Antibody

Multiple Sclerosis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Ocrelizumab is a recombinant humanized monoclonal antibody directed against CD20-expressing B-cells. Ocrelizumab is a glycosylated immunoglobulin G1 (IgG1) with a molecular mass of approximately 145 kDa.</p><p>OCREVUS (ocrelizumab) injection for intravenous infusion is a preservative-free, sterile, clear or slightly opalescent, and colorless to pale brown solution supplied in single-dose vials. Each mL of solution contains 30 mg ocrelizumab, glacial acetic acid (0.25 mg), polysorbate 20 (0.2 mg), sodium acetate trihydrate (2.14 mg), and trehalose dihydrate (40 mg) at pH 5.3.</p></section>

OCREVUS

ocrelizumab

10 ML ocrelizumab 30 MG/ML Injection

Ocrevus

10 ML ocrelizumab 30 MG/ML Injection [Ocrevus]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event 

Prescribing Information

Medication Guide 

Submit MSL Request 

Reimbursement Information 

Pharmacy List 

How To Order Ocrevus 

Billing & Coding Guide 

Coverage Authorization Request 

Coverage Authorization Appeals - Patients New to Ocrevus 

Coverage Authorization Appeals - Patients Converting to Ocrevus

Coverage Authorization Appeals - Patients to Remain on Ocrevus

Letter of Medical Necessity - Patients New to Ocrevus

Letter of Medical Necessity - Patients Converting to Ocrevus

Letter of Medical Necessity - Patients to Remain on Ocrevus

Ocrevus Start Form 

Ocrevus Start Form - Online Portal 

Patient Consent Form 

Patient Consent Form - Spanish

My Patient Solutions - HCP Portal (for managing service requests)

Enroll in Patient Savings Program 

Genentech Patient Assistance Program Application - Prescriber Form 

Infusion Referral Form 

Infusion Site Options

Other HCP Resources: Access

Other HCP Resources

Ocrevus Welcome Guide

About Ocrevus 

Side Effects

Receiving Ocrevus Infusion

Ocrevus Connects 

Ocrevus Cost Information

Instructions for Use: Multiple Sclerosis 